Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001564590-17-002993
Filing Date
2017-03-01
Accepted
2017-02-28 21:51:00
Documents
12
Period of Report
2017-02-28

Document Format Files

Seq Description Document Type Size
1 6-K pbmd-6k_20170228.htm 6-K 18770
2 EX-99.1 pbmd-ex991_150.htm EX-99.1 2010100
3 GRAPHIC g2017030101215974417548.jpg GRAPHIC 2038
4 GRAPHIC g2017030101215978917550.jpg GRAPHIC 2170
5 GRAPHIC g2017030101215675917545.jpg GRAPHIC 2038
6 GRAPHIC g2017030101215635117544.jpg GRAPHIC 4005
7 GRAPHIC g2017030101215634817543.jpg GRAPHIC 5454
8 GRAPHIC g2017030101215979317551.jpg GRAPHIC 2683
9 GRAPHIC g2017030101215979517552.jpg GRAPHIC 2438
10 GRAPHIC g2017030101215686517547.jpg GRAPHIC 2439
11 GRAPHIC g2017030101215676417546.jpg GRAPHIC 1995
12 GRAPHIC g2017030101215976217549.jpg GRAPHIC 2170
  Complete submission text file 0001564590-17-002993.txt   2069276
Mailing Address LEVEL 12, 95 PITT STREET SYDNEY, NEW SOUTH WALES C3 2000
Business Address LEVEL 12, 95 PITT STREET SYDNEY, NEW SOUTH WALES C3 2000 612 9276 1224
Prima BioMed Ltd (Filer) CIK: 0001506184 (see all company filings)

EIN.: 000000000
Type: 6-K | Act: 34 | File No.: 001-35428 | Film No.: 17651201
SIC: 2834 Pharmaceutical Preparations